Cancer Staging Manual

The AJCC has created a set of desk reference resource materials designed to provide in-depth, easy-to-access information for doctors and other medical professionals staging cancer patients, and for cancer registrars abstracting cancer cases.

Cancer Staging Manual

The AJCC has created a set of desk reference resource materials designed to provide in-depth information for doctors, medical professionals staging cancer patients, and cancer registrars abstracting cancer cases. ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

 

  AJCC Cancer Staging Manual, 8th Edition

 
9783319406176.jpgThe AJCC Cancer Staging Manual, 8th Edition is available for purchase. 

Significantly expanded and developed by international disease site expert panels, the Eighth Edition AJCC Cancer Staging Manual brings together all the currently available knowledge on staging of cancer at various anatomic sites. In this edition, evidence-based TNM staging is supplemented, as appropriate, by selected molecular markers and newly acquired insights into the molecular underpinnings of cancer. This edition features 12 entirely new staging systems, a wide range of changed or new staging definitions, and a refined emphasis on a personalized-medicine approach.

Purchase Here


 

 

 

Errata


 

This list contains important errata identified in the first printing of the AJCC Cancer Staging Manual, 8th Edition, and is effective for hard copy manuals purchased from September 2016 to present.  This list includes errors of omission and only critical errata that affect the meaning of a cancer staging system. Errata are tracked by staff and updated weekly. If you have identified an erratum not listed here, please email laurameyer@facs.org.​ 
 

Date Updated

Chapter or Part No.

Chapter or Part Title

Section

Page

Column

Before Correction

After Correction

12/9/2016

9

Nasopharynx

Definition of Primary Tumor (T)

107

2

No definition for Tis

Tis: Carcinoma in situ (insert row between T0 and T1)

12/9/2016

38

Bone

WHO Classification of Tumors

472

2

8540 Malignant peripheral nerve sheath tumor

9540 Malignant peripheral nerve sheath tumor

12/9/2016

55

Ovary, Fallopian Tube and Primary Peritoneal Carcinoma

WHO Classification of Tumors

682

1

8260 Adult granulosa cell tumor

8620 Adult granulosa cell tumor

12/9/2016

55

Ovary, Fallopian Tube and Primary Peritoneal Carcinoma

WHO Classification of Tumors

682

1

8542 Solid pseudopapillary neoplasm

8452 Solid pseudopapillary neoplasm

12/9/2016

55

Ovary, Fallopian Tube and Primary Peritoneal Carcinoma

WHO Classification of Tumors

682

1

8960 Paraganglioma

8960 Wilms tumor

12/9/2016

55

Ovary, Fallopian Tube and Primary Peritoneal Carcinoma

WHO Classification of Tumors

682

1

8963 Extra-gastrointestinal stromal tumor

8936 Extra-gastrointestinal stromal tumor

12/9/2016

7

Lip and Oral Cavity

AJCC Prognostic Stage Groups

91

2

No stage 0

insert row above T1   N0   M0  I:
Tis   N0   M0   0

12/9/2016

16

Esophagus and Esophagogastric Junction

Anatomy

187

n/a

Table 16.1 Primary site of esophageal cancer based on proximal edge of tumor

Table 16.1 Anatomy of esophageal cancer primary site by ICD-O-3 topography codes

12/9/2016

7

Lip and Oral Cavity

Rules for Classification > Pathological Classification > Pathological assessment of ENE

85

1

Only ENEma is used to define pathological ENE(+) nodal status

ENEmi and ENEma are used to define pathological ENE(+) nodal status

12/9/2016

7

Lip and Oral Cavity

Rules for Classification > Pathological Classification > Pathological assessment of ENE

85

1

Only ENEma is used to define pathological ENE nodal status (Fig. 7.5). ENEmi versus ENE n will not affect current nodal staging, but data collection is recommended to allow standardization of data collection and future analysis.

ENEmi and ENEma are used to define pathological ENE nodal status (Fig. 7.5). ENEmi versus ENE will affect current nodal staging, and data collection is recommended to allow standardization of data collection and future analysis.

12/2/2016

54

Corpus Uteri - Sarcoma

AJCC Prognostic Stage Groups

675

2

Incorrect table title: Leiomyosarcoma and Endometrial Stromal Sarcoma

Correct table title: Adenosarcoma

12/2/2016

54

Corpus Uteri - Sarcoma

AJCC Prognostic Stage Groups

675

2

Incorrect table title: Adenosarcoma

Correct table title: Leiomyosarcoma and Endometrial Stromal Sarcoma

12/2/2016

74

Thyroid - Medullary

Prognostic Factors > Additional Factors Recommended for Clinical Care

896

2

Incorrect heading: Sporadic or Medullary MTC

Sporadic or Hereditary MTC

12/2/2016

62

Urinary Bladder

AJCC Prognostic Stage Groups

764

1

T4b N0 M0 IVA

T4b Any N M0 IVA

11/18/2016

All

All

n/a

n/a

n/a

Effective date for 8th Edition staging rules: January 1, 2017

Effective date for 8th Edition staging rules: January 1, 2018

11/18/2016

73

Thyroid - Differentiated and Anaplastic

WHO Classification of Tumors

874

1

Code omitted

8260 Papillary carcinoma of the thyroid

11/18/2016

73

Thyroid - Differentiated and Anaplastic

WHO Classification of Tumors

874

1

8050 Papillary carcinoma

8050 Papillary carcinoma, NOS

11/11/2016

67

Uveal Melanoma

Definition of Regional Lymph Node (N)

812

2

No definition for NX and N0

NX     Regional lymph nodes cannot be assessed
N0     No regional lymph node involvement

11/11/2016

71

Ocular Adnexal Lymphoma

Definition of Distant Metastasis (M)

852

1

No definition for M1

M1: Evidence of involvement of other extranodal sites

11/11/2016

12

Nasal Cavity and Paranasal Sinuses

WHO Classification of Tumors

138

1

8429 Atypical Carcinoid

8249 Atypical Carcinoid

11/11/2016

68

Retinoblastoma

AJCC Prognostic Stage Groups

826

1, 2

 

Add T, N or H after Any in the clinical and pathological stage tables.

11/4/2016

58

Prostate

AJCC Prognostic Stage Groups

724

2

Any T, N0, M1, Any PSA, Any G, IVB

Any T, Any N, M1, Any PSA, Any G, IVB

11/4/2016

II

Head and Neck

Members of the Head and Neck Expert Panel

53

1

Panel member name omitted

Shirley Jordan Seay, PhD, OCN, CTR - Data Collection Core Representative

10/28/2016

55

Ovary, Fallopian Tube and Primary Peritoneal Carcinoma

AJCC Prognostic Stage Groups

688

2

When T is T3a, T3b, T3c, N is N0, N1

When T is T3a, T3b, T3c, N is NX, N0, N1

10/28/2016

58

Prostate

Definition of Histologic Grade Group

724

1

Grade Group 4, Gleason Score 8, Gleason Pattern 4+4

Grade Group 4, Gleason Score 8, Gleason Pattern 4+4, 3+5, 5+3

10/28/2016

58

Prostate

AJCC Prognostic Stage Groups

724

2

cT1a-c, cT2a N0 M0 PSA≥ 10 < 20 G1 IIA

cT1a-c, cT2a, pT2 N0 M0 PSA≥ 10 < 20 G1 IIA

10/28/2016

60

Kidney

AJCC Prognostic Stage Groups

744

1

T3    N0     M0     III

T3    NX, N0    M0   III

10/28/2016

61

Renal Pelvis and Ureter

AJCC Prognostic Stage Groups

754

1

T4 N0 M0 Stage IV

T4 NX, N0 M0 Stage IV

10/28/2016

52

Cervix Uteri

Author List

649

n/a

…Ian S. Hagemann, Esther Oliva, Lorraine Portelance…

…Ian S. Hageman, Lorraine Portelance…

10/28/2016

54

Corpus Uteri - Sarcoma

Author List

671

n/a

…Ian S. Hagemann, Matthew A. Powell…

...Ian S. Hagemann, Esther Oliva, Matthew A. Powell…

10/28/2016

73

Thyroid - Differentiated and Anaplastic

Imaging

877

2

Most patients will be clinical MX, as routine use of cross-sectional or functional (RAI)…

Most patients will be clinical M0, as routine use of cross-sectional or functional (RAI)…

 ​

 

 Publishing History

 
Editions of the AJCC Cancer Staging Manual
 
The publication dates and effective dates for past editions of the AJCC Cancer Staging Manual are:
 
Edition​ ​Publication Year ​Effective Year ​Resources
1​ ​1977 ​1978 AJCC 1st Ed Cancer Staging Manual
​2 ​1983 ​1984 AJCC 2nd Ed Cancer Staging Manual
​3 ​1988 ​1989 AJCC 3rd Ed Cancer Staging Manual
​4 ​1992 ​1993 AJCC 4th Edition Cancer Staging Manual​
​5 ​1997 ​1998 AJCC 5th Ed Cancer Staging Manual
​6 ​2002 ​2003

AJCC 6th Ed Cancer Staging Manual Part 1

AJCC 6th Ed Cancer Staging Manual Part 2

​7 ​2009 ​2010 AJCC 7th Ed Cancer Staging Manual
​8 ​2016  ​2018
Purchase Here